Isabelle Cludts

1.3k total citations
15 papers, 671 citations indexed

About

Isabelle Cludts is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Isabelle Cludts has authored 15 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Isabelle Cludts's work include T-cell and Retrovirus Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Isabelle Cludts is often cited by papers focused on T-cell and Retrovirus Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Isabelle Cludts collaborates with scholars based in United Kingdom, Belgium and Italy. Isabelle Cludts's co-authors include Paul J. Farrell, Arsène Burny, Daniel Portetelle, Hélène Gras, Victor Claes, Alfredo Cravador, André Tartar, Meenu Wadhwa, Louis Droogmans and Robin Thorpe and has published in prestigious journals such as Nature, The Journal of Immunology and Journal of Virology.

In The Last Decade

Isabelle Cludts

14 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Cludts United Kingdom	10	294	214	145	114	103	15	671
R Bredehorst Germany	16	339 1.2×	300 1.4×	194 1.3×	104 0.9×	77 0.7×	32	889
Olga Padilla Spain	14	405 1.4×	197 0.9×	102 0.7×	51 0.4×	60 0.6×	20	701
A. Reboul France	18	444 1.5×	254 1.2×	79 0.5×	106 0.9×	67 0.7×	45	986
Bruce A. Jacobson United States	14	661 2.2×	313 1.5×	104 0.7×	61 0.5×	210 2.0×	21	1.1k
T J Fleming United States	10	533 1.8×	262 1.2×	106 0.7×	86 0.8×	70 0.7×	10	865
P. Wijngaard Netherlands	11	387 1.3×	264 1.2×	68 0.5×	86 0.8×	61 0.6×	26	943
N Ramesh United States	12	696 2.4×	251 1.2×	91 0.6×	83 0.7×	64 0.6×	19	1.0k
Tamiko Nakajima Japan	18	192 0.7×	623 2.9×	57 0.4×	52 0.5×	129 1.3×	63	1.0k
R. Aston United Kingdom	19	262 0.9×	395 1.8×	211 1.5×	209 1.8×	42 0.4×	38	980
Joseph Dukes United Kingdom	7	145 0.5×	238 1.1×	151 1.0×	64 0.6×	32 0.3×	13	547

Countries citing papers authored by Isabelle Cludts

Since Specialization

Citations

This map shows the geographic impact of Isabelle Cludts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Cludts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Cludts more than expected).

Fields of papers citing papers by Isabelle Cludts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Cludts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Cludts. The network helps show where Isabelle Cludts may publish in the future.

Co-authorship network of co-authors of Isabelle Cludts

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Cludts. A scholar is included among the top collaborators of Isabelle Cludts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Cludts. Isabelle Cludts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wadhwa, Meenu, et al.. (2025). The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring. Frontiers in Immunology. 16. 1550655–1550655. 1 indexed citations

Wadhwa, Meenu, et al.. (2021). The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring. Frontiers in Immunology. 12. 636420–636420. 13 indexed citations

Cludts, Isabelle, et al.. (2017). Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab. Cytokine. 96. 16–23. 25 indexed citations

Cludts, Isabelle, Francesca Romana Spinelli, Francesca Morello, et al.. (2017). Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”. Cytokine. 101. 70–77. 1 indexed citations

Cludts, Isabelle, Anthony Meager, Robin Thorpe, & Meenu Wadhwa. (2013). Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples. Journal of Immunological Methods. 395(1-2). 37–44. 9 indexed citations

Cludts, Isabelle, Anthony Meager, Robin Thorpe, & Meenu Wadhwa. (2010). Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assay. Cytokine. 50(2). 129–137. 10 indexed citations

Stebbings, Richard, Lucy Findlay, David Eastwood, et al.. (2007). “Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics. The Journal of Immunology. 179(5). 3325–3331. 222 indexed citations

Cludts, Isabelle & Paul J. Farrell. (1998). Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein. Journal of Virology. 72(3). 1862–1869. 49 indexed citations

Farrell, Paul J., et al.. (1997). Epstein-Barr virus genes and cancer cells. Biomedicine & Pharmacotherapy. 51(6-7). 258–267. 24 indexed citations

10.

Droogmans, Louis, Isabelle Cludts, Y. Cleuter, et al.. (1994). Expression of interleukin 6 receptors and interleukin 6 mRNA by bovine leukaemia virus-induced tumour cells. Cytokine. 6(6). 641–646. 7 indexed citations

11.

Burny, Arsène, Luc Willems, Isabelle Callebaut, et al.. (1994). Bovine Leukaemia Virus: biology and mode of transformation. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 213–234. 13 indexed citations

12.

Cludts, Isabelle, et al.. (1993). Cloning and characterization of the tandemly arranged bovine lymphotoxin and tumour necrosis factor-alpha genes. Cytokine. 5(4). 336–341. 33 indexed citations

13.

Droogmans, Louis, Isabelle Cludts, Y. Cleuter, R. Kettmann, & A. Burny. (1992). Nucleotide sequence of bovine interleukin-6 cDNA. DNA sequence. 2(6). 411–413. 37 indexed citations

14.

Cludts, Isabelle, et al.. (1992). Sequence of bovine interleukin 7. DNA sequence. 3(1). 55–59. 4 indexed citations

15.

Claes, Victor, Daniel Portetelle, Isabelle Cludts, et al.. (1988). The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature. 332(6163). 454–455. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact